1. Auckland Cancer Society Research Centre, School of Medical Sciences, University of Auckland, New Zealand;2. Waikato Clinical School, University of Auckland, New Zealand;3. Kea Therapeutics Ltd, Auckland, New Zealand
Abstract:
N-Aliphatic ester analogues of the non-opioid ketamine (1) retain effective anaesthetic/analgesic properties while minimising ketamine’s psychomimetic side-effects. We show that the anaesthetic/analgesic properties of these ester analogues depend critically on the length (from 2 to 4 carbons), polarity and steric cross-section of the aliphatic linker chain. More stable amide and ethylsulfone analogues generally showed weaker anaesthetic/analgesic activity. There was no correlation between the anaesthetic/analgesic properties of the compounds and their binding affinities for the N-methyl-d-aspartate (NMDA) receptor.